Should I buy or sell iRhythm Technologies stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last year. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" IRTC shares. View IRTC analyst ratings or view top-rated stocks .

What is iRhythm Technologies' stock price target for 2024?

7 analysts have issued twelve-month price objectives for iRhythm Technologies' shares. Their IRTC share price targets range from $110.00 to $165.00. On average, they predict the company's stock price to reach $135.11 in the next twelve months. This suggests a possible upside of 20.5% from the stock's current price. View analysts price targets for IRTC or view top-rated stocks among Wall Street analysts .

How have IRTC shares performed in 2024?

iRhythm Technologies' stock was trading at $107.04 at the beginning of the year. Since then, IRTC stock has increased by 4.7% and is now trading at $112.12. View the best growth stocks for 2024 here .

When is iRhythm Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our IRTC earnings forecast .

How were iRhythm Technologies' earnings last quarter?

iRhythm Technologies, Inc. (NASDAQ:IRTC) announced its quarterly earnings results on Thursday, February, 22nd. The company reported ($1.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.60) by $0.66. The business had revenue of $132.51 million for the quarter, compared to the consensus estimate of $131.14 million. iRhythm Technologies had a negative trailing twelve-month return on equity of 56.38% and a negative net margin of 25.05%.

What ETFs hold iRhythm Technologies' stock?

ETFs with the largest weight of iRhythm Technologies (NASDAQ:IRTC) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC) , Fidelity Digital Health ETF (FDHT) , ROBO Global Healthcare Technology and Innovation ETF (HTEC) , SPDR S&P Health Care Equipment ETF (XHE) , ROBO Global Robotics & Automation ETF (ROBO) , BNY Mellon Innovators ETF (BKIV) , Harbor Health Care ETF (MEDI) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) .

What guidance has iRhythm Technologies issued on next quarter's earnings?

iRhythm Technologies updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $575.0 million-$585.0 million, compared to the consensus revenue estimate of $581.1 million.

What is Kevin M. King's approval rating as iRhythm Technologies' CEO?

20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com . Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of iRhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA) , Alibaba Group (BABA) , Salesforce (CRM) , Block (SQ) , Teladoc Health (TDOC) , Trade Desk (TTD) , Advanced Micro Devices (AMD) , Intel (INTC) , Broadcom (AVGO) and Boeing (BA) .

When did iRhythm Technologies IPO?

iRhythm Technologies (IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Who are iRhythm Technologies' major shareholders?

iRhythm Technologies' stock is owned by many different institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (1.33%), WoodTrust Financial Corp (0.05%), Diversified Trust Co (0.02%), CHICAGO TRUST Co NA (0.01%) and Los Angeles Capital Management LLC (0.01%). Insiders that own company stock include Daniel G Wilson , David A Vort, Douglas Devine , Kevin M King, Mark J Day , Merz Cathleen Noel Bairey , Patrick Michael Murphy and Quentin S Blackford . View institutional ownership trends .

How do I buy shares of iRhythm Technologies?

Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Top-Rated StocksTop-Rated

NASDAQ:IRTC

iRhythm Technologies (IRTC) Stock Price, News & Analysis

→ Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad)

Free IRTC Stock Alerts

$112.12

+0.63 (+0.57%)

(As of 04/18/2024 ET)

Compare

Today's Range: $109.86
▼
$114.47
50-Day Range: $102.09
▼
$121.38
52-Week Range: $70.24
▼
$140.23

Volume: 261,499 shs
Average Volume: 432,365 shs
Market Capitalization: $3.49 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $135.11

Get iRhythm Technologies alerts:

iRhythm Technologies MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 20.5% Upside
$135.11 Price Target
Short Interest: Bearish
8.19% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.29
Based on 5 Articles This Week
Insider Trading: Selling Shares
$4.27 M Sold Last Quarter
Proj. Earnings Growth: Growing
From ($3.14) to ($1.98) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.60 out of 5 stars

Medical Sector

862nd out of 918 stocks

Surgical & Medical Instruments Industry

85th out of 92 stocks

2.5

Analyst's Opinion

Consensus Rating
iRhythm Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
iRhythm Technologies has only been the subject of 3 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
8.19% of the outstanding shares of iRhythm Technologies have been sold short.
Short Interest Ratio / Days to Cover
iRhythm Technologies has a short interest ratio ("days to cover") of 5.6.
Change versus previous month
Short interest in iRhythm Technologies has recently increased by 3.24%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
iRhythm Technologies does not currently pay a dividend.
Dividend Growth
iRhythm Technologies does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for IRTC.

2.4

News and Social Media Coverage

News Sentiment
iRhythm Technologies has a news sentiment score of 1.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for iRhythm Technologies this week, compared to 5 articles on an average week.
Search Interest
Only 1 people have searched for IRTC on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of -88% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, iRhythm Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,274,942.00 in company stock.
Percentage Held by Insiders
Only 0.43% of the stock of iRhythm Technologies is held by insiders.

0.6

Earnings and Valuation

Earnings Growth
Earnings for iRhythm Technologies are expected to grow in the coming year, from ($3.14) to ($1.98) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of iRhythm Technologies is -27.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of iRhythm Technologies is -27.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
iRhythm Technologies has a P/B Ratio of 16.37. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About iRhythm Technologies Stock (NASDAQ:IRTC)

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

IRTC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

IRTC Stock News Headlines

April 18, 2024 | globenewswire.com

iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024

April 14, 2024 | americanbankingnews.com

iRhythm Technologies, Inc. (NASDAQ:IRTC) Given Consensus Rating of "Buy" by Brokerages

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 8, 2024 | markets.businessinsider.com

24 HOUR DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm

April 8, 2024 | investing.com

IRTC DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action “ IRTC

April 8, 2024 | businesswire.com

IRTC DEADLINE TODAY: ROSEN, A RANKED AND LEADING FIRM, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action – IRTC

April 8, 2024 | prnewswire.com

Shareholders that lost money on iRhythm Technologies, Inc.(IRTC) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

April 6, 2024 | morningstar.com

Lost Money on iRhythm Technologies, Inc. (IRTC)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 6, 2024 | markets.businessinsider.com

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm

April 5, 2024 | businesswire.com

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against iRhythm Technologies, Inc. (IRTC)

April 5, 2024 | finance.yahoo.com

Loss-Making iRhythm Technologies, Inc. (NASDAQ:IRTC) Expected To Breakeven In The Medium-Term

April 5, 2024 | prnewswire.com

Investors who lost money on iRhythm Technologies, Inc.(IRTC) should contact The Gross Law Firm about pending Class Action - IRTC

April 4, 2024 | prnewswire.com

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against iRhythm Technologies, Inc. - IRTC

April 2, 2024 | stockhouse.com

INVESTOR DEADLINE MONDAY: iRhythm Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - IRTC

April 2, 2024 | prnewswire.com

iRhythm Technologies, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - IRTC

April 1, 2024 | prnewswire.com

iRhythm Technologies, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - IRTC

March 30, 2024 | prnewswire.com

IRTC DEADLINE NOTICE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action - IRTC

March 29, 2024 | prnewswire.com

IRHYTHM SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against iRhythm Technologies, Inc. - IRTC

March 29, 2024 | prnewswire.com

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm

March 29, 2024 | prnewswire.com

Class Action Filed Against iRhythm Technologies, Inc. (IRTC) Seeking Recovery for Investors - Contact The Gross Law Firm

March 28, 2024 | stockhouse.com

IMMINENT IRTC DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds iRhythm Technologies, Inc. Investors to Join the Class Action Lawsuit!

March 27, 2024 | prnewswire.com

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against iRhythm Technologies, Inc. - IRTC

March 27, 2024 | stockhouse.com

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm

March 27, 2024 | prnewswire.com

Shareholders that lost money on iRhythm Technologies, Inc. (IRTC) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

March 26, 2024 | prnewswire.com

The Gross Law Firm Notifies iRhythm Technologies, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - IRTC

March 25, 2024 | stockhouse.com

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm

See More Headlines

Receive IRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/22/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/02/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:IRTC
CUSIP: N/A
CIK: 1388658
Web: www.irhythmtech.com
Phone: (415) 632-5700
Fax: N/A
Employees: 2,000
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $135.11
High Stock Price Target: $165.00
Low Stock Price Target: $110.00
Potential Upside/Downside: +19.9%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 7 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($4.05)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-123,410,000.00
Net Margins: -25.05%
Pretax Margin: -24.90%
Return on Equity: -56.38%
Return on Assets: -28.63%

Debt

Debt-to-Equity Ratio: 0.17
Current Ratio: 2.15
Quick Ratio: 2.02

Sales & Book Value

Annual Sales: $492.68 million
Price / Sales: 7.12
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $6.85 per share
Price / Book: 16.45

Miscellaneous

Outstanding Shares: 31,120,000
Free Float: 30,987,000
Market Cap: $3.51 billion
Optionable: Optionable
Beta: 1.30

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. Quentin S. Blackford (Age 45)
President, CEO & Director
Comp: $2.15M
Mr. Brice Bobzien CPA (Age 45)
Chief Financial Officer
Comp: $685.12k
Dr. Minang P. Turakhia M.D. (Age 50)
M.S., Chief Medical & Scientific Officer and Executive VP of Product Innovation
Comp: $1M
Mr. Patrick Michael Murphy J.D. (Age 45)
Chief Business & Legal Officer
Comp: $1.28M
Mr. Douglas J. Devine (Age 54)
Executive Advisor
Comp: $800k
Mr. Chad M. Patterson (Age 42)
Chief Commercial Officer
Comp: $771.51k
Mr. Marc Rosenbaum (Age 52)
Senior VP of Finance & Chief Accounting Officer
Mr. Mark J. Day Ph.D. (Age 53)
Chief Technology Officer
Comp: $718.76k
Mr. Daniel G. Wilson (Age 41)
Executive VP of Corporate Development & Investor Relations
Comp: $670.09k
Ms. Sumi Shrishrimal (Age 45)
Executive VP & Chief Risk Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

IRTC Stock Analysis - Frequently Asked Questions

Should I buy or sell iRhythm Technologies stock right now?: 7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last year. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" IRTC shares.
View IRTC analyst ratings or view top-rated stocks.
What is iRhythm Technologies' stock price target for 2024?: 7 analysts have issued twelve-month price objectives for iRhythm Technologies' shares. Their IRTC share price targets range from $110.00 to $165.00. On average, they predict the company's stock price to reach $135.11 in the next twelve months. This suggests a possible upside of 20.5% from the stock's current price.
View analysts price targets for IRTC or view top-rated stocks among Wall Street analysts.
How have IRTC shares performed in 2024?: iRhythm Technologies' stock was trading at $107.04 at the beginning of the year. Since then, IRTC stock has increased by 4.7% and is now trading at $112.12.
View the best growth stocks for 2024 here.
When is iRhythm Technologies' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our IRTC earnings forecast.
How were iRhythm Technologies' earnings last quarter?: iRhythm Technologies, Inc. (NASDAQ:IRTC) announced its quarterly earnings results on Thursday, February, 22nd. The company reported ($1.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.60) by $0.66. The business had revenue of $132.51 million for the quarter, compared to the consensus estimate of $131.14 million. iRhythm Technologies had a negative trailing twelve-month return on equity of 56.38% and a negative net margin of 25.05%.
What ETFs hold iRhythm Technologies' stock?: ETFs with the largest weight of iRhythm Technologies (NASDAQ:IRTC) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), ROBO Global Healthcare Technology and Innovation ETF (HTEC), SPDR S&P Health Care Equipment ETF (XHE), ROBO Global Robotics & Automation ETF (ROBO), BNY Mellon Innovators ETF (BKIV), Harbor Health Care ETF (MEDI) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).

What guidance has iRhythm Technologies issued on next quarter's earnings?: iRhythm Technologies updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $575.0 million-$585.0 million, compared to the consensus revenue estimate of $581.1 million.
What is Kevin M. King's approval rating as iRhythm Technologies' CEO?: 20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of iRhythm Technologies own?: Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA).
When did iRhythm Technologies IPO?: iRhythm Technologies (IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.
Who are iRhythm Technologies' major shareholders?: iRhythm Technologies' stock is owned by many different institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (1.33%), WoodTrust Financial Corp (0.05%), Diversified Trust Co (0.02%), CHICAGO TRUST Co NA (0.01%) and Los Angeles Capital Management LLC (0.01%). Insiders that own company stock include Daniel G Wilson, David A Vort, Douglas Devine, Kevin M King, Mark J Day, Merz Cathleen Noel Bairey, Patrick Michael Murphy and Quentin S Blackford.
View institutional ownership trends.
How do I buy shares of iRhythm Technologies?: Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:IRTC) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

iRhythm Technologies (IRTC) Stock Price, News & Analysis

iRhythm Technologies MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About iRhythm Technologies Stock (NASDAQ:IRTC)

IRTC Stock Price History

IRTC Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

IRTC Stock Analysis - Frequently Asked Questions

Overall MarketRank^™